For example, inhibition of protein phosphatase 2 activator (PTPA) in colorectal cancer leads to activation of oncogenic pathways (e.g., MAPK, catenin beta 1 [CTNNB1]) and cellular stress responses. Here, CTNNB1 is linked to colorectal cancer.